182 related articles for article (PubMed ID: 38930898)
21. Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators.
Serhan CN
J Thromb Haemost; 2009 Jul; 7 Suppl 1():44-8. PubMed ID: 19630766
[TBL] [Abstract][Full Text] [Related]
22. Specialized pro-resolving lipid mediators in the inflammatory response: An update.
Bannenberg G; Serhan CN
Biochim Biophys Acta; 2010 Dec; 1801(12):1260-73. PubMed ID: 20708099
[TBL] [Abstract][Full Text] [Related]
23. Maresins: anti-inflammatory pro-resolving mediators with therapeutic potential.
Li QF; Hao H; Tu WS; Guo N; Zhou XY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7442-7453. PubMed ID: 32706084
[TBL] [Abstract][Full Text] [Related]
24. The n-3 docosapentaenoic acid (DPA): A new player in the n-3 long chain polyunsaturated fatty acid family.
Drouin G; Rioux V; Legrand P
Biochimie; 2019 Apr; 159():36-48. PubMed ID: 30716358
[TBL] [Abstract][Full Text] [Related]
25. Novel n-3 immunoresolvents: structures and actions.
Dalli J; Colas RA; Serhan CN
Sci Rep; 2013; 3():1940. PubMed ID: 23736886
[TBL] [Abstract][Full Text] [Related]
26. Stereoselective Synthesis, Pro-resolution, and Anti-inflammatory Actions of RvD5
Ervik K; Reinertsen AF; Koenis DS; Dalli J; Hansen TV
J Nat Prod; 2023 Nov; 86(11):2546-2553. PubMed ID: 37879110
[TBL] [Abstract][Full Text] [Related]
27. [Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids].
Nowak JZ
Postepy Hig Med Dosw (Online); 2010 Mar; 64():115-32. PubMed ID: 20354260
[TBL] [Abstract][Full Text] [Related]
28. Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications.
Valente M; Dentoni M; Bellizzi F; Kuris F; Gigli GL
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956787
[TBL] [Abstract][Full Text] [Related]
29. Stereoselective Synthesis, Configurational Assignment and Biological Evaluations of the Lipid Mediator RvD2
Reinertsen AF; Primdahl KG; De Matteis R; Dalli J; Hansen TV
Chemistry; 2022 Feb; 28(7):e202103857. PubMed ID: 34890076
[TBL] [Abstract][Full Text] [Related]
30. A new synthetic protectin D1 analog 3-oxa-PD1
Nesman JI; Chen O; Luo X; Ji RR; Serhan CN; Hansen TV
Org Biomol Chem; 2021 Mar; 19(12):2744-2752. PubMed ID: 33687402
[TBL] [Abstract][Full Text] [Related]
31. Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators.
Serhan CN
Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):157-63. PubMed ID: 19008087
[TBL] [Abstract][Full Text] [Related]
32. Specialized pro-resolving mediator network: an update on production and actions.
Chiang N; Serhan CN
Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
[TBL] [Abstract][Full Text] [Related]
33. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.
Serhan CN; Chiang N
Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S200-15. PubMed ID: 17965751
[TBL] [Abstract][Full Text] [Related]
34. Docosapentaenoic acid (DPA, 22:5n-3) ameliorates inflammation in an ulcerative colitis model.
Zheng Z; Dai Z; Cao Y; Shen Q; Zhang Y
Food Funct; 2019 Jul; 10(7):4199-4209. PubMed ID: 31250861
[TBL] [Abstract][Full Text] [Related]
35. Selective identification of specialized pro-resolving lipid mediators from their biosynthetic double di-oxygenation isomers.
Hansen TV; Dalli J; Serhan CN
RSC Adv; 2016; 6(34):28820-28829. PubMed ID: 27525060
[TBL] [Abstract][Full Text] [Related]
36. Resolvins and protectins: mediating solutions to inflammation.
Kohli P; Levy BD
Br J Pharmacol; 2009 Oct; 158(4):960-71. PubMed ID: 19594757
[TBL] [Abstract][Full Text] [Related]
37. n - 3 Docosapentaenoic acid: the iceberg n - 3 fatty acid.
Ghasemi Fard S; Cameron-Smith D; Sinclair AJ
Curr Opin Clin Nutr Metab Care; 2021 Mar; 24(2):134-138. PubMed ID: 33315722
[TBL] [Abstract][Full Text] [Related]
38. Anti-Inflammatory Function of Fatty Acids and Involvement of Their Metabolites in the Resolution of Inflammation in Chronic Obstructive Pulmonary Disease.
Kotlyarov S; Kotlyarova A
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884621
[TBL] [Abstract][Full Text] [Related]
39. Pro-Resolving Lipid Mediators in the Pathophysiology of Asthma.
Kytikova O; Novgorodtseva T; Denisenko Y; Antonyuk M; Gvozdenko T
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31216723
[TBL] [Abstract][Full Text] [Related]
40. A New E-Series Resolvin: RvE4 Stereochemistry and Function in Efferocytosis of Inflammation-Resolution.
Libreros S; Shay AE; Nshimiyimana R; Fichtner D; Martin MJ; Wourms N; Serhan CN
Front Immunol; 2020; 11():631319. PubMed ID: 33643307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
